|
1
|
Fernandes Q, Inchakalody VP, Merhi M,
Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A,
Al-Zaidan L, Mohsen MO, et al: Emerging COVID-19 variants and their
impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med.
54:524–540. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kostoff RN, Briggs MB, Kanduc D, Dewanjee
S, Kandimalla R, Shoenfeld Y, Porter AL and Tsatsakis A: Modifiable
contributing factors to COVID-19: A comprehensive review. Food Chem
Toxicol. 171(113511)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rasmussen SA, Khoury MJ and Del Rio C:
Precision public health as a key tool in the COVID-19 Response.
JAMA. 324:933–934. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Du P, Li D, Wang A, Shen S, Ma Z and Li X:
A systematic review and meta-analysis of risk factors associated
with severity and death in COVID-19 Patients. Can J Infect Dis Med
Microbiol. 2021(6660930)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Scavone C, Mascolo A, Rafaniello C,
Sportiello L, Trama U, Zoccoli A, Bernardi FF, Racagni G, Berrino
L, Castaldo G, et al: Therapeutic strategies to fight COVID-19:
Which is the status artis ? Br J Pharmacol. 179:2128–2148.
2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kostoff RN, Briggs MB, Kanduc D, Shores
DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A and Spandidos
DA: Contributing factors common to COVID-19 and gastrointestinal
cancer. Oncol Rep. 47(16)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sorrentino S, Cacia M, Leo I, Polimeni A,
Sabatino J, Spaccarotella CAM, Mongiardo A, De Rosa S and Indolfi
C: B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease
Severity-A Meta-Analysis. J Clin Med. 9(2957)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Osawa I, Okamoto K, Ikeda M, Otani A,
Wakimoto Y, Yamashita M, Shinohara T, Kanno Y, Jubishi D, Kurano M,
et al: Dynamic changes in fibrinogen and D-dimer levels in COVID-19
patients on nafamostat mesylate. J Thromb Thrombolysis. 51:649–656.
2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Düz ME, Balcı A and Menekşe E: D-dimer
levels and COVID-19 severity: systematic review and meta-analysis.
Tuberk Toraks. 68:353–360. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Gungor B, Atici A, Baycan OF, Alici G,
Ozturk F, Tugrul S, Asoglu R, Cevik E, Sahin I and Barman HA:
Elevated D-dimer levels on admission are associated with severity
and increased risk of mortality in COVID-19: A systematic review
and meta-analysis. Am J Emerg Med. 39:173–179. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wibowo A, Pranata R, Akbar MR, Purnomowati
A and Martha JW: Prognostic performance of troponin in COVID-19: A
diagnostic meta-analysis and meta-regression. Int J Infect Dis.
105:312–318. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang
YB, Yan YQ, Akdis CA and Gao YD: Clinical characteristics of 140
patients infected with SARS-CoV-2 in Wuhan, China. Allergy.
75:1730–1741. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chen P, Zhang Y, Wen Y, Guo J, Bai W, Jia
J, Ma Y and Xu Y: Clinical and demographic characteristics of
cluster cases and sporadic cases of coronavirus disease 2019
(COVID-19) in 141 patients in the main district of Chongqing,
China, between january and february 2020. Med Sci Monit.
26(e923985)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Guo F, Xie J, Wu W, Li S, Hu M, Li J,
Jiang L, Du B, Tong Z and Qiu H: Clinical characteristics and
outcomes of critically ill patients with coronavirus disease 2019
with hypotension in China: A retrospective cohort study. Ann
Palliat Med. 10:8536–8546. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Warusevitane A, Karunatilake D, Sim J,
Smith C and Roffe C: early diagnosis of pneumonia in severe stroke:
Clinical features and the diagnostic role of C-Reactive Protein.
PLoS One. 11(e0150269)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang G, Wu C, Zhang Q, Wu F, Yu B, Lv J,
Li Y, Li T, Zhang S, Wu C, et al: C-Reactive protein level may
predict the risk of COVID-19 Aggravation. Open Forum Infect Dis.
7(ofaa153)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li
B, Song X and Zhou X: Prognostic value of interleukin-6, C-reactive
protein, and procalcitonin in patients with COVID-19. J Clin Virol.
127(104370)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen X, Yang Y, Huang M, Liu L, Zhang X,
Xu J, Geng S, Han B, Xiao J and Wan Y: Differences between COVID-19
and suspected then confirmed SARS-CoV-2-negative pneumonia: A
retrospective study from a single center. J Med Virol.
92:1572–1579. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sharifpour M, Rangaraju S, Liu M, Alabyad
D, Nahab FB, Creel-Bulos CM and Jabaley CS: Emory COVID-19 Quality
& Clinical Research Collaborative. C-Reactive protein as a
prognostic indicator in hospitalized patients with COVID-19. PLoS
One. 15(e0242400)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pousa PA, Mendonça TSC, Oliveira EA and
Simões-E-Silva AC: Extrapulmonary manifestations of COVID-19 in
children: A comprehensive review and pathophysiological
considerations. J Pediatr (Rio J). 97:116–139. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Peerschke EI, Valentino A, So RJ, Shulman
S and Ravinder : Thromboinflammation supports complement
activation in cancer patients with COVID-19. Front Immunol.
12(716361)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Batatinha HAP, Krüger K and Rosa Neto JC:
Thromboinflammation and COVID-19: The role of exercise in the
prevention and treatment. Front Cardiovasc Med.
7(582824)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Carvalho T: Extrapulmonary SARS-CoV-2
manifestations. Nat Med. 26(1806)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Goshua G, Pine AB, Meizlish ML, Chang CH,
Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, et al:
Endotheliopathy in COVID-19-associated coagulopathy: Evidence from
a single-centre, cross-sectional study. Lancet Haematol.
7:e575–e582. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Maier JA: Endothelial cells and magnesium:
Implications in atherosclerosis. Clin Sci (Lond). 122:397–407.
2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mazilu L, Katsiki N, Nikolouzakis TK,
Aslanidis MI, Lazopoulos G, Kouretas D, Tsatsakis A, Suceveanu AI,
Stoian AP, Parepa IR, et al: Thrombosis and Haemostasis challenges
in COVID-19-Therapeutic perspectives of heparin and tissue-type
plasminogen activator and potential toxicological reactions-a mini
review. Food Chem Toxicol. 148(111974)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Broman M, Wilsson AMJ, Hansson F and
Klarin B: Analysis of Hypo- and Hyperphosphatemia in an Intensive
Care Unit Cohort. Anesth Analg. 124:1897–1905. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fakhrolmobasheri M, Vakhshoori M,
Heidarpour M, Najimi A, Mozafari AM and Rezvanian H:
Hypophosphatemia in coronavirus disease 2019 (COVID-19),
complications, and considerations: A systematic review. Biomed Res
Int. 2022(1468786)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bego T, Meseldžić N, Prnjavorac B,
Prnjavorac L, Marjanović D, Azevedo R, Pinto E, Duro M, Couto C and
Almeida A: Association of trace element status in COVID-19 patients
with disease severity. J Trace Elem Med Biol.
74(127055)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Stancioiu F, Papadakis GZ, Kteniadakis S,
Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection
of SARS-CoV2 with clinical implications (Review). Int J Mol Med.
46:489–508. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Marginean CM, Popescu M, Vasile CM,
Cioboata R, Mitrut P, Popescu IAS, Biciusca V, Docea AO, Mitrut R,
Marginean IC, et al: Challenges in the differential diagnosis of
COVID-19 Pneumonia: A pictorial review. Diagnostics (Basel).
12(2823)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Skalny AV, Rink L, Ajsuvakova OP, Aschner
M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos
DA, Aaseth J, et al: Zinc and respiratory tract infections:
Perspectives for COVID-19 (Review). Int J Mol Med. 46:17–26.
2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Neagu M, Calina D, Docea AO, Constantin C,
Filippini T, Vinceti M, Drakoulis N, Poulas K, Nikolouzakis TK,
Spandidos DA and Tsatsakis A: Back to basics in COVID-19: Antigens
and antibodies-Completing the puzzl. J Cell Mol Med. 25:4523–4533.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Calina D, Hernández AF, Hartung T, Egorov
AM, Izotov BN, Nikolouzakis TK, Tsatsakis A, Vlachoyiannopoulos PG
and Docea AO: Challenges and scientific prospects of the newest
generation of mRNA-Based vaccines against SARS-CoV-2. Life (Basel).
11(907)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
WHO: Clinical management of COVID-19:
Living guideline, 13 January 2023. Clin Manag COVID-19 LIVING
Guidel Sept 2022 2023, 2023.
|
|
37
|
Tello-Montoliu A, Marín F, Roldán V,
Mainar L, López MT, Sogorb F, Vicente V and Lip GY: A multimarker
risk stratification approach to non-ST elevation acute coronary
syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin
D-dimer levels. J Intern Med. 262:651–658. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Covington EW, Roberts MZ and Dong J:
Procalcitonin monitoring as a guide for antimicrobial therapy: A
review of current literature. Pharmacotherapy. 38:569–581.
2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Aslan A, Aslan C, Zolbanin NM and Jafari
R: Acute respiratory distress syndrome in COVID-19: possible
mechanisms and therapeutic management. Pneumonia (Nathan).
13(14)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wu T, Zuo Z, Kang S, Jiang L, Luo X, Xia
Z, Liu J, Xiao X, Ye M and Deng M: Multi-organ Dysfunction in
Patients with COVID-19: A systematic review and meta-analysis.
Aging Dis. 11:874–894. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical Characteristics
of 138 Hospitalized Patients With 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lippi G and Plebani M: Procalcitonin in
patients with severe coronavirus disease 2019 (COVID-19): A
meta-analysis. Clin Chim Acta. 505:190–191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Giannis D, Ziogas IA and Gianni P:
Coagulation disorders in coronavirus infected patients: COVID-19,
SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol.
127(104362)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Léonard-Lorant I, Delabranche X, Séverac
F, Helms J, Pauzet C, Collange O, Schneider F, Labani A, Bilbault
P, Molière S, et al: Acute Pulmonary Embolism in Patients with
COVID-19 at CT Angiography and Relationship to d-Dimer Levels.
Radiology. 296:E189–E191. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Cheng L, Li H, Li L, Liu C, Yan S, Chen H
and Li Y: Ferritin in the coronavirus disease 2019 (COVID-19): A
systematic review and meta-analysis. J Clin Lab Anal.
34(e23618)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Salvatici M, Barbieri B, Cioffi SMG,
Morenghi E, Leone FP, Maura F, Moriello G and Sandri MT:
Association between cardiac troponin I and mortality in patients
with COVID-19. Biomarkers. 25:634–640. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Orchard L, Baldry M, Nasim-Mohi M, Monck
C, Saeed K, Grocott MPW and Ahilanandan D: Vitamin-D levels and
intensive care unit outcomes of a cohort of critically ill COVID-19
patients. Clin Chem Lab Med. 59:1155–1163. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Güven M and Gültekin H: The effect of
high-dose parenteral vitamin D(3) on COVID-19-related inhospital
mortality in critical COVID-19 patients during intensive care unit
admission: An observational cohort study. Eur J Clin Nutr.
75:1383–1388. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lukacova S, Sørensen BS, Alsner J,
Overgaard J and Horsman MR: The impact of hypoxia on the activity
of lactate dehydrogenase in two different pre-clinical tumour
models. Acta Oncol. 47:941–947. 2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fialek B, Pruc M, Smereka J, Jas R,
Rahnama-Hezavah M, Denegri A, Szarpak A, Jaguszewski MJ, Peacock FW
and Szarpak L: Diagnostic value of lactate dehydrogenase in
COVID-19: A systematic review and meta-analysis. Cardiol J.
29:751–758. 2022.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Poggiali E, Zaino D, Immovilli P, Rovero
L, Losi G, Dacrema A, Nuccetelli M, Vadacca GB, Guidetti D,
Vercelli A, et al: Lactate dehydrogenase and C-reactive protein as
predictors of respiratory failure in CoVID-19 patients. Clin Chim
Acta. 509:135–138. 2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ali N: Elevated level of C-reactive
protein may be an early marker to predict risk for severity of
COVID-19. J Med Virol. 92:2409–2411. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Smilowitz NR, Kunichoff D, Garshick M,
Shah B, Pillinger M, Hochman JS and Berger JS: C-reactive protein
and clinical outcomes in patients with COVID-19. Eur Heart J.
42:2270–2279. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Medetalibeyoglu A, Catma Y, Senkal N,
Ormeci A, Cavus B, Kose M, Bayramlar OF, Yildiz G, Akyuz F,
Kaymakoglu S and Tukek T: The effect of liver test abnormalities on
the prognosis of COVID-19. Ann Hepatol. 19:614–621. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Osman W, Al Fahdi F, Al Salmi I, Al
Khalili H, Gokhale A and Khamis F: serum calcium and vitamin D
levels: Correlation with severity of COVID-19 in hospitalized
patients in Royal Hospital, Oman. Int J Infect Dis. 107:153–163.
2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Sun JK, Zhang WH, Zou L, Liu Y, Li JJ, Kan
XH, Dai L, Shi QK, Yuan ST, Yu WK, et al: Serum calcium as a
biomarker of clinical severity and prognosis in patients with
coronavirus disease 2019. Aging (Albany NY). 12:11287–11295.
2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Alemzadeh E, Alemzadeh E, Ziaee M, Abedi A
and Salehiniya H: The effect of low serum calcium level on the
severity and mortality of Covid patients: A systematic review and
meta-analysis. Immunity, Inflamm Dis. 9:1219–1228. 2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Malinowska J, Małecka-Giełdowska M,
Bańkowska D, Borecka K and Ciepiela O: Hypermagnesemia and
hyperphosphatemia are highly prevalent in patients with COVID-19
and increase the risk of death. Int J Infect Dis. 122:543–549.
2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bailey RL, Gahche JJ, Lentino CV, Dwyer
JT, Engel JS, Thomas PR, Betz JM, Sempos CT and Picciano MF:
Dietary supplement use in the United States, 2003-2006. J Nutr.
141:261–266. 2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Blaine J, Chonchol M and Levi M: Renal
control of calcium, phosphate, and magnesium homeostasis. Clin J Am
Soc Nephrol. 10:1257–1272. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Uwitonze AM and Razzaque MS: Role of
Magnesium in Vitamin D Activation and Function. J Am Osteopath
Assoc. 118:181–189. 2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Stevens JS, Moses AA, Nickolas TL, Husain
SA and Mohan S: Increased mortality associated with hypermagnesemia
in severe COVID-19 Illness. Kidney360. 2:1087–1094. 2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Ko JH, Park GE, Lee JY, Lee JY, Cho SY, Ha
YE, Kang CI, Kang JM, Kim YJ, Huh HJ, et al: Predictive factors for
pneumonia development and progression to respiratory failure in
MERS-CoV infected patients. J Infect. 73:468–475. 2016.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Thakur B, Dubey P, Benitez J, Torres JP,
Reddy S, Shokar N, Aung K, Mukherjee D and Dwivedi AK: A systematic
review and meta-analysis of geographic differences in comorbidities
and associated severity and mortality among individuals with
COVID-19. Sci Rep. 11(8562)2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Petrakis D, Nikolouzakis TK, Karzi V,
Vardavas AI, Vardavas CI and Tsatsakis A: The growing anthropogenic
immune deficit and the COVID-19 pandemic. Public Heal Toxicol.
1(1)2021.
|
|
66
|
Tsatsakis A, Petrakis D, Nikolouzakis TK,
Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis
C, Aschner M and Hernández AF: COVID-19, an opportunity to
reevaluate the correlation between long-term effects of
anthropogenic pollutants on viral epidemic/pandemic events and
prevalence. Food Chem Toxicol. 141(111418)2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Skalny AV, Timashev PS, Aschner M, Aaseth
J, Chernova LN, Belyaev VE, Grabeklis AR, Notova SV, Lobinski R,
Tsatsakis A, et al: Serum zinc, copper, and other biometals are
associated with COVID-19 severity markers. Metabolites.
11(244)2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Agathokleous E, Barceló D, Iavicoli I,
Tsatsakis A and Calabrese EJ: Disinfectant-induced hormesis: An
unknown environmental threat of the application of disinfectants to
prevent SARS-CoV-2 infection during the COVID-19 pandemic? Environ
Pollut. 292(Pt B)(118429)2022.PubMed/NCBI View Article : Google Scholar
|
